Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06921902

Glycemic Metrics and Patterns in People With and Without Prediabetes

The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Diabetes and Obesity Care

Bend, Oregon, 97702, United States

Location status: Recruiting

Location contact

Eden Miller, D.O.

CONTACT

About this study

This is a non-pivotal, non-randomized, multi-center, prospective, non-significant risk to evaluate the glycemic profiles of people with and without a prediabetes diagnosis using continuous glucose monitoring. Up to 2000 subjects will be enrolled in up to 20 sites. Approximately 50% of evaluable subjects will have a prediabetes diagnosis.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject must be at least 18 years of age.
  • Subject must be willing and able to provide written signed and dated informed consent.

Exclusion criteria

  • Subject has a diagnosis of type 1 diabetes, type 2 diabetes, or gestational diabetes.
  • Subject is known to be currently practicing a low-carbohydrate or ketogenic diet at the time of enrollment.
  • Subject is known to be pregnant at the time of enrollment.
  • Subject has known allergy to medical grade adhesive, isopropyl alcohol and/or ethyl alcohol used to disinfect skin.
  • Subject is currently on any form of treatment indicated for the treatment of diabetes.
  • Subject is currently on any form of medication indicated for weight loss.

Treatment and study plan

FreeStyle Libre 3

Device

Abbott Sensor Based Glucose Monitoring System (FreeStyle Libre 3 System)

Other names: FreeStyle Libre 3 Monitoring System

Primary outcomes

  1. Characterize the glycemic profiles of people with and without a prediabetes diagnosis.

    Time frame: up to 50 days

    This is a data collection study.

Study contacts

Contact information is provided by the study sponsor or research team.

MOHAMED NADA, PhD

CONTACT

[email protected]

5107495416

Sponsors and collaborators

Lead sponsor

Abbott Diabetes Care

Industry

Registry information

Official study title

Observation and Identification of Glycemic Metrics and Patterns in People With and Without Prediabetes (PREMAP)

Acronym: PREMAP

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Apr 10, 2025
Registry last updated
Apr 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.